{"entity":{"type":"insider","cik":"0001808980","url":"/insider/0001808980","json_url":"/insider/0001808980.json","name":"Bhavnagri Veer","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":16,"first":"2020-08-05","last":"2023-02-14","span_basis":"filed_date"},"name_variants":[{"name":"Bhavnagri Veer","source":"filing","n_filings":16,"first_seen":"2020-08-05","last_seen":"2023-02-14"}],"transactions":[{"id":8267561,"accession":"0001593968-23-000317","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-23-000317","line_url":"/filing/0001593968-23-000317#line-1","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":6.85,"price_display":"6.85","price_state":"stated","total_value":20550.0,"total_display":"20,550.00","shares_owned_after":577677.0,"shares_owned_after_display":"577,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-13","filed_date":"2023-02-14","scope":"insider"},{"id":8689473,"accession":"0001593968-23-000168","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-23-000168","line_url":"/filing/0001593968-23-000168#line-1","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":7.04,"price_display":"7.04","price_state":"stated","total_value":21120.0,"total_display":"21,120.00","shares_owned_after":580677.0,"shares_owned_after_display":"580,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-18","scope":"insider"},{"id":6687544,"accession":"0001593968-22-001742","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001593968-22-001742","line_url":"/filing/0001593968-22-001742#line-1","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5602.0,"shares_display":"5,602","price_per_share":7.5306,"price_display":"7.53","price_state":"stated","total_value":42186.4212,"total_display":"42,186.42","shares_owned_after":583677.0,"shares_owned_after_display":"583,677","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":6313178,"accession":"0001214659-22-004086","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001214659-22-004086","line_url":"/filing/0001214659-22-004086#line-1","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8849.0,"shares_display":"8,849","price_per_share":7.6802,"price_display":"7.68","price_state":"stated","total_value":67962.0898,"total_display":"67,962.09","shares_owned_after":413841.0,"shares_owned_after_display":"413,841","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-15","filed_date":"2022-03-17","scope":"insider"},{"id":5481350,"accession":"0001214659-21-009625","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-009625","line_url":"/filing/0001214659-21-009625#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":24.7689,"price_display":"24.77","price_state":"stated","total_value":123844.5,"total_display":"123,844.50","shares_owned_after":421669.0,"shares_owned_after_display":"421,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-17","scope":"insider"},{"id":4748448,"accession":"0001214659-21-008761","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-008761","line_url":"/filing/0001214659-21-008761#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.9988,"price_display":"21.00","price_state":"stated","total_value":104994.0,"total_display":"104,994.00","shares_owned_after":421353.0,"shares_owned_after_display":"421,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-16","filed_date":"2021-08-17","scope":"insider"},{"id":5481317,"accession":"0001214659-21-007588","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-007588","line_url":"/filing/0001214659-21-007588#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":21.5506,"price_display":"21.55","price_state":"stated","total_value":107753.0,"total_display":"107,753.00","shares_owned_after":421353.0,"shares_owned_after_display":"421,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-15","filed_date":"2021-07-16","scope":"insider"},{"id":5302054,"accession":"0001214659-21-006631","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-006631","line_url":"/filing/0001214659-21-006631#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":25.32,"price_display":"25.32","price_state":"stated","total_value":126600.0,"total_display":"126,600.00","shares_owned_after":421353.0,"shares_owned_after_display":"421,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-15","filed_date":"2021-06-16","scope":"insider"},{"id":4345762,"accession":"0001214659-21-005767","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-005767","line_url":"/filing/0001214659-21-005767#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":150000.0,"total_display":"150,000.00","shares_owned_after":421353.0,"shares_owned_after_display":"421,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-20","scope":"insider"},{"id":4115570,"accession":"0001214659-21-005621","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-005621","line_url":"/filing/0001214659-21-005621#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":28.2951,"price_display":"28.30","price_state":"stated","total_value":141475.5,"total_display":"141,475.50","shares_owned_after":421353.0,"shares_owned_after_display":"421,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-17","scope":"insider"},{"id":4850717,"accession":"0001214659-21-004267","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-21-004267","line_url":"/filing/0001214659-21-004267#line-3","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9394.0,"shares_display":"9,394","price_per_share":32.0138,"price_display":"32.01","price_state":"stated","total_value":300737.6372,"total_display":"300,737.64","shares_owned_after":421959.0,"shares_owned_after_display":"421,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-16","scope":"insider"},{"id":4850711,"accession":"0001214659-21-004267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-004267","line_url":"/filing/0001214659-21-004267#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":606.0,"shares_display":"606","price_per_share":32.6398,"price_display":"32.64","price_state":"stated","total_value":19779.7188,"total_display":"19,779.72","shares_owned_after":421353.0,"shares_owned_after_display":"421,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-15","filed_date":"2021-04-16","scope":"insider"},{"id":4239648,"accession":"0001214659-21-003242","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-21-003242","line_url":"/filing/0001214659-21-003242#line-4","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9600.0,"shares_display":"9,600","price_per_share":37.7925,"price_display":"37.79","price_state":"stated","total_value":362808.0,"total_display":"362,808.00","shares_owned_after":399551.0,"shares_owned_after_display":"399,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":4239644,"accession":"0001214659-21-003242","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-21-003242","line_url":"/filing/0001214659-21-003242#line-3","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6623.0,"shares_display":"6,623","price_per_share":38.1595,"price_display":"38.16","price_state":"stated","total_value":252730.3685,"total_display":"252,730.37","shares_owned_after":409151.0,"shares_owned_after_display":"409,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":4239641,"accession":"0001214659-21-003242","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-21-003242","line_url":"/filing/0001214659-21-003242#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":38.15,"price_display":"38.15","price_state":"stated","total_value":15260.0,"total_display":"15,260.00","shares_owned_after":399151.0,"shares_owned_after_display":"399,151","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-15","filed_date":"2021-03-17","scope":"insider"},{"id":2741467,"accession":"0001214659-20-008504","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-008504","line_url":"/filing/0001214659-20-008504#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":400000.0,"total_display":"400,000.00","shares_owned_after":353902.0,"shares_owned_after_display":"353,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-06","filed_date":"2020-10-08","scope":"insider"},{"id":2741456,"accession":"0001214659-20-008378","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001214659-20-008378","line_url":"/filing/0001214659-20-008378#line-4","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16215.0,"shares_display":"16,215","price_per_share":36.2053,"price_display":"36.21","price_state":"stated","total_value":587068.9395,"total_display":"587,068.94","shares_owned_after":362687.0,"shares_owned_after_display":"362,687","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-02","scope":"insider"},{"id":2741450,"accession":"0001214659-20-008378","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-20-008378","line_url":"/filing/0001214659-20-008378#line-3","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7985.0,"shares_display":"7,985","price_per_share":37.0274,"price_display":"37.03","price_state":"stated","total_value":295663.789,"total_display":"295,663.79","shares_owned_after":354702.0,"shares_owned_after_display":"354,702","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-02","scope":"insider"},{"id":2741442,"accession":"0001214659-20-008378","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-008378","line_url":"/filing/0001214659-20-008378#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":800.0,"shares_display":"800","price_per_share":37.725,"price_display":"37.72","price_state":"stated","total_value":30180.0,"total_display":"30,180.00","shares_owned_after":353902.0,"shares_owned_after_display":"353,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-02","scope":"insider"},{"id":3097185,"accession":"0001214659-20-007671","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-20-007671","line_url":"/filing/0001214659-20-007671#line-3","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24600.0,"shares_display":"24,600","price_per_share":35.35,"price_display":"35.35","price_state":"stated","total_value":869610.0,"total_display":"869,610.00","shares_owned_after":354302.0,"shares_owned_after_display":"354,302","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-03","scope":"insider"},{"id":3097181,"accession":"0001214659-20-007671","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-007671","line_url":"/filing/0001214659-20-007671#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400.0,"shares_display":"400","price_per_share":35.89,"price_display":"35.89","price_state":"stated","total_value":14356.0,"total_display":"14,356.00","shares_owned_after":353902.0,"shares_owned_after_display":"353,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-01","filed_date":"2020-09-03","scope":"insider"},{"id":2841695,"accession":"0001214659-20-006805","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001214659-20-006805","line_url":"/filing/0001214659-20-006805#line-3","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16450.0,"shares_display":"16,450","price_per_share":37.2886,"price_display":"37.29","price_state":"stated","total_value":613397.47,"total_display":"613,397.47","shares_owned_after":353902.0,"shares_owned_after_display":"353,902","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"},{"id":2841687,"accession":"0001214659-20-006805","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001214659-20-006805","line_url":"/filing/0001214659-20-006805#line-2","is_derivative":false,"issuer_cik":"0001737287","issuer_name":"Allogene Therapeutics, Inc.","issuer_ticker":"ALLO","issuer_name_source":null,"issuer_url":"/issuer/0001737287","owner_cik":"0001808980","owner_name":"Bhavnagri Veer","owner_url":"/insider/0001808980","role":"Officer (General Counsel)","officer_title":"General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15103.0,"shares_display":"15,103","price_per_share":36.4645,"price_display":"36.46","price_state":"stated","total_value":550723.3435,"total_display":"550,723.34","shares_owned_after":370352.0,"shares_owned_after_display":"370,352","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2020-08-05","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":23,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001737287","name":"Allogene Therapeutics, Inc.","url":"/issuer/0001737287","role":"Officer (General Counsel)","n_filings":16,"first_seen":"2020-08-05","last_seen":"2023-02-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808980","retrieved_at":"2026-08-21T07:27:42+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}